GlassScriptPhysician profile
Cory A Vaughn
NPI 1821417833
$7,487.30
in general payments reported to CMS, 2019-2025
22 companies · $918 in 2025
The $918 reported for 2025 was more than what 78% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,918 · 2020: $158 · 2021: $1,137 · 2022: $1,995 · 2023: $551 · 2024: $811 · 2025: $918.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,279.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,310.78 | 2022-2025 | Inspire |
| Stryker Corporation | $1,311.20 | 2019-2025 | Scopis Ent |
| Medtronic USA, INC. | $999.25 | 2019 | |
| Intersect Ent, INC. | $775.77 | 2019-2022 | |
| Cochlear Americas | $598.19 | 2019-2025 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Smith+Nephew, INC. | $252.83 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $242.32 | 2019-2024 | Dupixent, Libtayo |
| Med-El Corporation | $220.78 | 2019-2024 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit |
| Glaxosmithkline, LLC. | $162.49 | 2021-2025 | Nucala |
| Acclarent, INC | $116.67 | 2019-2022 | |
| Medtronic, INC. | $77.21 | 2021-2025 | Stealthstation S8 Platform, Ligasure |
| Karl Storz Endoscopy-America | $74.01 | 2022 | |
| Advanced Bionics, LLC | $73.81 | 2020-2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Genzyme Corporation | $63.18 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $45.59 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $32.64 | 2021-2023 | |
| Organogenesis INC. | $25.47 | 2025 | Novachor |
| Neurent Medical Limited | $25.24 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Csl Behring | $22.20 | 2023 | Kcentra |
| Kaleo, INC. | $22.20 | 2020-2021 | |
| Hikma Pharmaceuticals USA | $17.98 | 2024 | Ryaltris |
| Aerin Medical INC. | $17.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cory Vaughn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.